Curis, Inc. (CRIS) Financials

CRIS Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 29.7 million 17.0 million
Dec. 31, 2025 20.0 million 14.5 million
Sept. 30, 2025 27.6 million 42.3 million
June 30, 2025 29.2 million 43.2 million

CRIS Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -9.0 million 575000
Dec. 31, 2025 -6.4 million 795000
Sept. 30, 2025 -5.6 million 924000
June 30, 2025 -8.0 million 1.1 million

CRIS Net Income

No data available :(

CRIS Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 15.0 million - 108000
Dec. 31, 2025 5.1 million - 1.6 million
Sept. 30, 2025 9.1 million - 2.0 million
June 30, 2025 10.1 million - 2.3 million

CRIS Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 193.6 million
Dec. 31, 2025 131.6 million
Sept. 30, 2025 15.7 million
June 30, 2025 12.6 million

CRIS Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 6.4 million 5.1 million -
Dec. 31, 2025 - 5.8 million 2.9 million -
Sept. 30, 2025 - 6.4 million 3.7 million -
June 30, 2025 - 7.5 million 3.5 million -

CRIS Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 8000
Dec. 31, 2025 1.1 million 36000
Sept. 30, 2025 3.2 million 15000
June 30, 2025 2.7 million 16000

CRIS Revenue by Segment
Graph available only for paid members. Upgrade to see it.

CRIS

Price: $0.42

52 week price:
0.38
3.13

Earnings Per Share: -0.58 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 479800

Ebitda: -14.2 million

Market Capitalization: 6.6 million

Links: